| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |